Evidence map›Paper›PMID 42251160›Full record

ArticleNPJ digital medicine2026

Measurement fidelity, not model complexity, governs individual cognitive trajectory prediction in Parkinson's disease.

Wei Lin, Sanjeet S Grewal

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wei LinDepartment of Neurologic Surgery, Mayo Clinic, Jacksonville, FL, USA. lin.wei@mayo.edu.ORCID http://orcid.org/0000-0003-2332-924X
Sanjeet S GrewalDepartment of Neurologic Surgery, Mayo Clinic, Jacksonville, FL, USA.

Funding

National Alzheimer's Coordinating CenterU24AG072122 · NIA · UNIVERSITY OF WASHINGTON · PI STEPHENS, KARI A · 2021 to 2025
$45.8M
NIA NIH HHS U24 AG072122
6 · The paper itself

Abstract

Whether individual-level cognitive trajectories in Parkinson's disease are predictable remains unresolved. Here, we provide convergent evidence that measurement fidelity, rather than model complexity, governs the prediction ceiling. We evaluated ten machine learning paradigm families across 26 configurations in two independent cohorts-the Parkinson's Progression Markers Initiative (PPMI, N = 1018) and the National Alzheimer's Coordinating Center (NACC, N = 523). Motor subtype classification succeeded as a positive control (AUROC = 0.869), while cognitive trajectory prediction from the Montreal Cognitive Assessment remained uninformative (AUROC = 0.581) across all methods, including 42 genetic features. Synthetic experiments confirmed that models recover trajectories at high signal-to-noise ratios but collapse uniformly at levels present in clinical screening data. Replacing coarse screening with detailed neuropsychological tests improved prediction in both cohorts (PPMI: Symbol Digit Modalities Test AUROC = 0.725 vs. MoCA 0.596; NACC: Logical Memory AUROC = 0.684 vs. MMSE 0.648). Within-patient trajectory R² = 0.20 for MoCA domains confirmed that approximately 80% of score variance represents non-signal variance. These findings redirect the clinical AI agenda from algorithm development toward measurement innovation: higher-frequency, higher-fidelity cognitive instruments are necessary before individual-level prediction becomes feasible.

Identifiers

PMID42251160
PMCPMC13572477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.